GO:0006497 protein lipidation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006497 protein lipidation is the covalent attachment of lipid groups to amino acids in a protein, a reversible post-translational modification that controls membrane targeting, protein stability, and signaling.
• Major lipidation types include S-palmitoylation, N-myristoylation, S-prenylation (farnesylation/geranylgeranylation), cholesterylation, and GPI anchoring, each with distinct enzymes and substrate specificities.
• Protein lipidation is essential for cell signaling, development, and immunity; its dysregulation is linked to cancer, neurodegeneration, and infectious diseases.
• Key enzymes such as ZDHHC palmitoyltransferases, NMT1/NMT2, and FNTA/FNTB prenyltransferases are attractive drug targets, and small-molecule modulators are under active development.
• Lipidation is exploited in therapeutics to improve peptide and protein drug half-life and membrane association.
• Studying lipidation requires specialized enrichment and characterization methods, including click chemistry, mass spectrometry, and metabolic labeling.
Description
Protein lipidation (GO:0006497) is a fundamental post-translational modification in which lipid moieties are covalently attached to amino acid residues of a protein. This process dramatically increases protein hydrophobicity and often directs proteins to cellular membranes, thereby influencing localization, trafficking, and interactions. Unlike many other modifications, lipidation encompasses a diverse set of chemically distinct attachments, including fatty acids (myristate, palmitate), isoprenoids (farnesyl, geranylgeranyl), cholesterol, and glycosylphosphatidylinositol (GPI) anchors. Each type is catalyzed by dedicated enzymes and can be reversed by specific depalmitoylases or other hydrolases, adding a dynamic layer of regulation. For researchers, protein lipidation is a critical node in signal transduction, membrane biology, and disease pathogenesis. Many oncoproteins, such as RAS, depend on lipidation for membrane targeting and transforming activity, making the lipidation machinery a prime target for therapeutic intervention. In neuroscience, lipidation of synaptic proteins regulates neurotransmission and is implicated in neurodegenerative disorders. The development of chemical probes and enrichment strategies has accelerated the mapping of the "lipidome" and the discovery of new lipidation events. Given its broad impact, understanding protein lipidation requires integrating biochemistry, cell biology, and advanced proteomics. This article provides a comprehensive overview of the definition, mechanisms, key genes, disease relevance, and cutting-edge research methods for GO:0006497, with a focus on how CRISPR-based models can elucidate causal roles.
protein lipidation At A Glance
| GO ID | GO:0006497 |
|---|---|
| GO term | protein lipidation |
| Ontology | biological_process |
| Synonym | lipid:protein modification, protein amino acid lipidation |
| Definition | The covalent attachment of lipid groups to an amino acid in a protein. |
| Major function | Covalent lipid attachment to proteins, controlling membrane targeting, stability, and signaling. |
| Major lipid types | Fatty acids (myristate, palmitate), isoprenoids (farnesyl, geranylgeranyl), cholesterol, GPI anchors. |
| Key enzymes | ZDHHC palmitoyltransferases, NMT1/NMT2, FNTA/FNTB, PORCN, HHAT. |
| Reversibility | Dynamic; depalmitoylases (e.g., APT1, APT2) remove palmitate. |
| Disease relevance | Cancer, neurodegeneration, infectious diseases, developmental disorders. |
What Is GO:0006497?
According to the Gene Ontology, protein lipidation (GO:0006497) is defined as the covalent attachment of lipid groups to an amino acid in a protein. This definition encompasses all forms of lipid modification, including but not limited to S-palmitoylation, N-myristoylation, S-prenylation, cholesterylation, and GPI anchor addition. The modification is enzymatic and typically occurs on specific cysteine, glycine, or serine residues, depending on the lipid type. Protein lipidation is a biological process that modulates protein function by altering hydrophobicity, membrane affinity, and protein-protein interactions.
Why Is protein lipidation Important in Cell Biology?
Protein lipidation is critically important because it serves as a primary mechanism for directing proteins to cellular membranes and organizing signaling complexes. It affects a large fraction of the proteome, with hundreds of proteins undergoing palmitoylation alone. Dysregulation of lipidation is causally linked to major human diseases, including cancer, where aberrant RAS lipidation drives tumor growth, and neurodegeneration, where altered palmitoylation contributes to protein aggregation and synaptic dysfunction. Moreover, the lipidation machinery is druggable, and small-molecule inhibitors are being explored as therapeutics. Understanding this process is therefore essential for both basic cell biology and translational medicine.
• Controls membrane targeting and trafficking of key signaling proteins such as RAS, G proteins, and SRC kinases.
• Regulates protein stability, interaction networks, and enzymatic activity.
• Essential for embryonic development; knockout of lipidation enzymes is often lethal in model organisms.
• Implicated in cancer: RAS prenylation and palmitoylation are required for oncogenic transformation.
• Linked to neurodegenerative diseases: altered palmitoylation of APP, BACE1, and huntingtin affects pathogenesis.
• Plays a role in immune signaling and host-pathogen interactions.
• Exploited in drug development to improve peptide and protein therapeutics via lipidation.
• Provides a dynamic and reversible switch, with depalmitoylases counteracting writers.
• Enables spatial and temporal control of signaling at membranes.
• Offers targets for chemical probes and small-molecule modulators.
What Happens During protein lipidation?
Substrate recognition and enzyme recruitment
In simple terms: First, the right enzyme finds the right protein and gets ready to attach a lipid.
Protein lipidation begins with the recognition of a substrate protein by a specific lipid-transferase enzyme. For N-myristoylation, NMT1 or NMT2 recognizes an N-terminal glycine after removal of the initiator methionine. For S-palmitoylation, ZDHHC enzymes bind substrate cysteines, often within hydrophobic or basic motifs. Prenylation enzymes (FNTA/FNTB) recognize C-terminal CAAX motifs. This step ensures specificity and is regulated by enzyme expression, localization, and accessory proteins.
Covalent lipid attachment
In simple terms: The enzyme chemically links a lipid molecule to the protein.
The catalytic step involves the formation of a covalent bond between the lipid and the target amino acid. For S-palmitoylation, a thioester bond forms between palmitate and cysteine. N-myristoylation creates an amide bond with glycine. Prenylation attaches a farnesyl or geranylgeranyl group to cysteine via a thioether bond. Cholesterylation and GPI anchoring involve more complex multi-step pathways in the endoplasmic reticulum. These modifications are often irreversible except for palmitoylation, which is dynamic.
Membrane insertion and protein re-localization
In simple terms: The lipid acts like a greasy anchor that pulls the protein to cell membranes.
Once lipidated, the hydrophobic lipid moiety inserts into lipid bilayers, driving the protein to membranes such as the plasma membrane, Golgi, or endosomes. This re-localization is crucial for signaling: for example, RAS must be prenylated and palmitoylated to reach the plasma membrane and activate downstream pathways. Membrane insertion also facilitates protein-protein interactions and the assembly of signaling complexes.
Reversal and dynamic regulation
In simple terms: Some lipids can be removed, allowing the protein to change location or activity.
S-palmitoylation is reversible; depalmitoylases such as APT1 (LYPLA1) and APT2 (LYPLA2) hydrolyze the thioester bond, releasing palmitate and allowing the protein to cycle between membranes and cytosol. This dynamicity is essential for processes like synaptic plasticity and cell migration. Other lipidation types, such as prenylation and myristoylation, are generally stable, but their effects can be modulated by downstream processing or protein degradation.
Downstream functional consequences
In simple terms: The lipid tag changes what the protein does, where it goes, and how it signals.
Lipidation affects protein stability, trafficking, and interaction partners. It can promote or inhibit enzyme activity, control vesicle fusion, and regulate immune signaling. In neurons, palmitoylation of AMPA receptors and other synaptic proteins modulates neurotransmission. In cancer, lipidation of oncoproteins like RAS and EGFR family members sustains proliferative signaling. Thus, the process is a central hub for cellular decision-making.
Key Genes Involved in GO:0006497 protein lipidation
The following genes encode the core enzymes, writers, erasers, and substrate proteins that mediate and regulate protein lipidation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ZDHHC2 | Palmitoyltransferase (writer) for many synaptic and signaling proteins | Knockout alters neuronal development and cancer cell proliferation |
| ZDHHC3 | Palmitoylates GABAA receptors and other substrates | Implicated in epilepsy and synaptic inhibition |
| ZDHHC7 | Palmitoylates sex steroid receptors and adhesion proteins | Linked to breast cancer and cell migration |
| ZDHHC9 | Palmitoylates RAS and other small GTPases | Mutations cause X-linked intellectual disability |
| ZDHHC20 | Palmitoylates EGFR and other growth factor receptors | Regulates cancer cell signaling and drug resistance |
| NMT1 | N-myristoyltransferase 1; attaches myristate to N-terminal glycine | Essential for viability; target in cancer and infectious diseases |
| NMT2 | N-myristoyltransferase 2; redundant with NMT1 | Knockout studies reveal overlapping functions |
| FNTA | Farnesyltransferase alpha subunit; prenylation of CAAX proteins | Target for cancer therapy (e.g., RAS) |
| FNTB | Farnesyltransferase beta subunit; catalytic subunit | Inhibitors developed for cancer and progeria |
| GGPS1 | Geranylgeranyl pyrophosphate synthase; supplies isoprenoid precursors | Knockout affects prenylation and cell growth |
| LYPLA1 (APT1) | Depalmitoylase; removes palmitate from proteins | Regulates RAS signaling and cancer cell invasion |
| LYPLA2 (APT2) | Depalmitoylase with distinct substrate specificity | Modulates synaptic function and neurodegeneration |
| PPT1 | Palmitoyl-protein thioesterase 1; lysosomal depalmitoylase | Mutations cause infantile neuronal ceroid lipofuscinosis |
| RAS (HRAS, KRAS, NRAS) | Small GTPase; requires prenylation and palmitoylation for membrane targeting | Oncogene; lipidation inhibitors are in clinical trials |
| GNAI1 | G protein alpha subunit; myristoylated and palmitoylated | Regulates GPCR signaling; knockout affects heart rate |
| PCDH10 | Protocadherin; palmitoylated in neurons | Implicated in autism and synaptic development |
| BACE1 | Beta-secretase; palmitoylated in Alzheimer's disease | Palmitoylation regulates its activity and amyloid production |
| Huntingtin | Palmitoylated at cysteine 214; affects trafficking | Mutant huntingtin shows altered palmitoylation in Huntington's disease |
How Is protein lipidation Regulated?
Protein lipidation is regulated at multiple levels. Enzyme expression and localization are controlled by transcription factors and signaling pathways, such as growth factor signaling that upregulates ZDHHC enzymes. The availability of lipid substrates (e.g., palmitoyl-CoA, farnesyl pyrophosphate) influences reaction rates. Depalmitoylases provide dynamic reversal, and their activity is regulated by phosphorylation and protein interactions. Additionally, accessory proteins and scaffolding complexes can target enzymes to specific substrates. In cancer, oncogenic signaling can enhance lipidation of RAS and other proteins, creating a feed-forward loop. Small molecules that modulate lipidation are being developed as chemical probes and therapeutics.
protein lipidation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KRAS | Cancer (pancreatic, lung, colorectal) | Knock-in of KRAS G12D with lipidation site mutations; KO of ZDHHC9 |
| ZDHHC9 | X-linked intellectual disability | KO in human iPSC-derived neurons; point mutation of catalytic domain |
| PPT1 | Infantile neuronal ceroid lipofuscinosis | KO in mouse or human neurons; knock-in of patient mutations |
| BACE1 | Alzheimer's disease | Palmitoylation-site point mutant knock-in; KO in APP transgenic mice |
| HTT | Huntington's disease | Knock-in of mutant HTT with C214S mutation; KO of ZDHHC enzymes |
Cancer
Protein lipidation is critically involved in cancer. RAS oncoproteins require prenylation and palmitoylation for plasma membrane localization and activation of downstream MAPK and PI3K pathways. Inhibitors of farnesyltransferase and palmitoyltransferases have been explored as anticancer agents, though with mixed clinical results. Other lipidation targets include EGFR, which is palmitoylated by ZDHHC20, affecting its stability and signaling. Depalmitoylases like APT1 can promote cancer cell invasion and metastasis. Thus, lipidation enzymes represent potential therapeutic targets.
Neurodegenerative diseases
Altered protein lipidation is linked to neurodegeneration. In Alzheimer's disease, palmitoylation of BACE1 and APP regulates amyloid-beta production. In Huntington's disease, mutant huntingtin shows decreased palmitoylation at cysteine 214, contributing to toxicity. Mutations in PPT1 cause infantile neuronal ceroid lipofuscinosis, a fatal neurodegenerative disorder. Palmitoylation of synaptic proteins is essential for neurotransmission, and its disruption may underlie cognitive deficits.
Infectious diseases
Many pathogens exploit host lipidation machinery. For example, HIV Nef protein is myristoylated, which is required for its function in immune evasion. The malaria parasite uses N-myristoyltransferases that are essential for its survival, making them drug targets. Antiviral and antiparasitic strategies targeting lipidation are under investigation.
Developmental and immune disorders
Mutations in ZDHHC9 cause X-linked intellectual disability, highlighting the importance of palmitoylation in brain development. In immune cells, lipidation of signaling proteins regulates T-cell activation and cytokine production. Defects in GPI anchor biosynthesis lead to paroxysmal nocturnal hemoglobinuria and other disorders.
From protein lipidation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ZDHHC20 palmitoylation of EGFR regulate tumor growth? | ZDHHC20 knockout cancer cell line; EGFR palmitoylation-site mutant knock-in |
| Is NMT1 essential for viability? | Inducible NMT1 knockout in human cell lines; rescue with NMT1 point mutants |
| How does APT1 depalmitoylation affect RAS signaling? | APT1 knockout and overexpression; RAS palmitoylation-site mutants |
| What is the role of PPT1 in neurodegeneration? | PPT1 knockout iPSC-derived neurons; knock-in of patient mutations |
| Can small molecules modulate palmitoylation? | Overexpression of ZDHHC enzymes with reporter substrates; chemical probe screening |
| Does palmitoylation of BACE1 affect amyloid production? | BACE1 palmitoylation-site mutant knock-in in APP-expressing cells |
How to Study the protein lipidation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Click chemistry labeling | Global palmitoylation levels and substrate identification | Profiling lipidation changes in cancer cells |
| Acyl-biotin exchange (ABE) | S-palmitoylation sites on proteins | Identifying palmitoylated proteins in neurons |
| Mass spectrometry | Site-specific lipidation and quantification | Mapping the lipidome in disease models |
| Fluorescence microscopy | Membrane localization and dynamics | Visualizing RAS trafficking |
| CRISPR knockout | Loss-of-function phenotypes | Testing essentiality of ZDHHC enzymes |
| Small-molecule inhibitors | Acute inhibition of lipidation enzymes | Assessing therapeutic potential |
| FRET biosensors | Real-time conformational changes | Monitoring depalmitoylation dynamics |
| Proximity ligation assay | Protein-protein interactions at membranes | Detecting enzyme-substrate complexes |
Chemical and metabolic labeling
Click chemistry-based probes, such as 17-ODYA or azide-functionalized palmitate analogs, enable metabolic labeling of palmitoylated proteins for detection and enrichment. These methods allow global profiling of lipidation dynamics and identification of new substrates.
Mass spectrometry-based proteomics
Mass spectrometry coupled with enrichment (e.g., acyl-biotin exchange, click chemistry) enables site-specific identification of lipidated peptides and quantification of lipidation changes. This approach is powerful for mapping the lipidome and discovering disease-associated alterations.
Imaging and cellular assays
Fluorescent lipid analogs and GFP-tagged proteins can visualize lipidation-dependent membrane targeting in live cells. FRET-based sensors and total internal reflection fluorescence (TIRF) microscopy reveal real-time dynamics at membranes.
Genetic and pharmacological perturbation
CRISPR knockout, RNAi, and small-molecule inhibitors (e.g., farnesyltransferase inhibitors, palmitoylation inhibitors) are used to dissect the functional consequences of lipidation. Rescue experiments with wild-type or lipidation-deficient mutants confirm specificity.
How CRISPR Can Be Used to Study GO:0006497 protein lipidation
Knockout
CRISPR knockout of lipidation enzymes (e.g., ZDHHC9, NMT1, FNTA) is used to study loss-of-function phenotypes, such as impaired membrane targeting of substrates and effects on cell growth. Knockout cell lines are valuable for validating drug targets and identifying compensatory pathways.
Point Mutation
Point mutations at lipidation sites (e.g., C214S in huntingtin, C186S in RAS) or in catalytic domains of enzymes (e.g., ZDHHC9) can be introduced via CRISPR to dissect specific functions without altering protein levels. These models are crucial for distinguishing lipidation-dependent from independent roles.
Knock-in
Knock-in of disease-associated mutations (e.g., PPT1 R122W, ZDHHC9 mutations) or tagged versions of enzymes (e.g., HA-ZDHHC20) allows study of mutant behavior and protein localization in a physiological context. Knock-in of reporter substrates enables real-time tracking of lipidation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of lipidation enzymes and substrates is used to amplify signaling and identify downstream effects. Overexpression of depalmitoylases like APT1 can reverse lipidation and test dynamic regulation.
How EDITGENE Supports protein lipidation Research
Researchers studying protein lipidation-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. CRISPR-based models provide a robust way to manipulate these genes with precision, enabling loss-of-function, point-mutation, knock-in, and overexpression studies in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for protein lipidation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| UGCG Knockout HEK293 Cell Line | EDJ-KQ2506 | Human | 7357 | Details Get a Quote |
| ATG7 Knockout HEK293 Cell Line | EDC90151 | Human | 10533 | Details Get a Quote |
| ALOX12B Knockout HEK293 Cell Line | EDC07792 | Human | 242 | Details Get a Quote |
| PORCN Knockout HEK293 Cell Line | EDJ-KQ14835 | Human | 64840 | Details Get a Quote |
| UGCG Knockout A-549 Cell Line | EDJ-KQ23102 | Human | 7357 | Details Get a Quote |
| UGCG Knockout HCT 116 Cell Line | EDJ-KQ23103 | Human | 7357 | Details Get a Quote |
| UGCG Knockout HeLa Cell Line | EDJ-KQ23104 | Human | 7357 | Details Get a Quote |
| ATG7 Knockout HeLa Cell Line | EDJ-KQ18266 | Human | 10533 | Details Get a Quote |
| ATG7 Knockout A-549 Cell Line | EDJ-KQ25486 | Human | 10533 | Details Get a Quote |
| ATG7 Knockout HCT 116 Cell Line | EDJ-KQ25487 | Human | 10533 | Details Get a Quote |
| ALOX12B Knockout HCT 116 Cell Line | EDJ-KQ26396 | Human | 242 | Details Get a Quote |
| PORCN Knockout A-549 Cell Line | EDJ-KQ45281 | Human | 64840 | Details Get a Quote |
| PORCN Knockout HCT 116 Cell Line | EDJ-KQ45282 | Human | 64840 | Details Get a Quote |
| PORCN Knockout HeLa Cell Line | EDJ-KQ45283 | Human | 64840 | Details Get a Quote |
| ATG7 Knockout VeroE6/TMPRSS2 Cell Line | EDJ-KZ102 | African green monkey | 10533 | Details Get a Quote |
Frequently Asked Questions About protein lipidation
What is protein lipidation (GO:0006497)?
Protein lipidation is the covalent attachment of lipid groups to amino acids in a protein, as defined by the Gene Ontology. It includes modifications like palmitoylation, myristoylation, and prenylation, and controls membrane targeting and signaling.
What are the main types of protein lipidation?
The main types are S-palmitoylation, N-myristoylation, S-prenylation (farnesylation and geranylgeranylation), cholesterylation, and GPI anchoring.
Which enzymes catalyze protein lipidation?
Key enzymes include ZDHHC palmitoyltransferases, N-myristoyltransferases (NMT1/NMT2), farnesyltransferases (FNTA/FNTB), and geranylgeranyltransferases.
What genes are involved in protein lipidation?
Genes include ZDHHC family members, NMT1, NMT2, FNTA, FNTB, GGPS1, LYPLA1, LYPLA2, and PPT1, among others.
How is protein lipidation regulated?
It is regulated by enzyme expression, substrate availability, and depalmitoylases that reverse the modification.
What diseases are linked to protein lipidation?
Diseases include cancer (e.g., RAS-driven tumors), neurodegenerative disorders (Alzheimer's, Huntington's), and developmental disorders like X-linked intellectual disability.
How can I study protein lipidation in the lab?
Common methods include click chemistry labeling, mass spectrometry, fluorescence microscopy, and CRISPR-based genetic perturbation.
What is the role of palmitoylation in cancer?
Palmitoylation is required for membrane targeting of oncoproteins like RAS and EGFR, and its inhibition can reduce tumor growth.
Can protein lipidation be targeted therapeutically?
Yes, small-molecule inhibitors of lipidation enzymes are being developed for cancer and infectious diseases.
What CRISPR models are available for lipidation research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for lipidation-related genes, as well as CRISPR library screening and bioinformatics services.
Conclusion
Protein lipidation (GO:0006497) is a versatile and essential post-translational modification that controls protein localization, stability, and signaling. Its dysregulation contributes to cancer, neurodegeneration, and infectious diseases, making it a promising therapeutic target. Advances in chemical tools, proteomics, and CRISPR-based models are accelerating our understanding of this process. EDITGENE provides comprehensive CRISPR solutions to help researchers dissect the causal roles of lipidation genes and translate these findings into new treatments.
References
- 1. Yuan Y et al.. 2024. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication.. Signal Transduct Target Ther 9(1):60 PMID: 38485938
- 2. Wang R et al.. 2022. Protein Lipidation Types: Current Strategies for Enrichment and Characterization.. Int J Mol Sci 23(4) PMID: 35216483
- 3. Ding W et al.. 2024. The Biosynthesis and Applications of Protein Lipidation.. Chem Rev 124(21):12176-12212 PMID: 39441663
- 4. Chen B et al.. 2018. Protein Lipidation in Cell Signaling and Diseases: Function, Regulation, and Therapeutic Opportunities.. Cell Chem Biol 25(7):817-831 PMID: 29861273
- 5. Wang Z et al.. 2023. Small-Molecule Modulation of Protein Lipidation: From Chemical Probes to Therapeutics.. Chembiochem 24(14):e202300071 PMID: 37059689
- 6. Menacho-Melgar R et al.. 2019. A review of lipidation in the development of advanced protein and peptide therapeutics.. J Control Release 295:1-12 PMID: 30579981
- 7. Charron G et al.. 2009. Chemical tools for understanding protein lipidation in eukaryotes.. Curr Opin Chem Biol 13(4):382-91 PMID: 19699139
- 8. Kuhlmann J. 2004. Protein lipidation.. Methods Mol Biol 283:217-20 PMID: 15197313
